Side Effects of Naltrexone and Gabapentin
The most common side effects of naltrexone are nausea (10%), headache (7%), dizziness (4%), and nervousness (4%), while gabapentin primarily causes dizziness, sedation, lack of coordination, and drowsiness—both medications require careful monitoring but have distinct safety profiles that should guide clinical decision-making.
Naltrexone Side Effects
Most Common Adverse Effects
Based on FDA labeling and clinical guidelines, naltrexone's side effect profile includes 1:
Gastrointestinal (most prominent):
- Nausea: 10% of patients (most common reason for discontinuation at 4.6-9.6%)
- Vomiting: 3%
- Abdominal pain/cramps
Neurological:
- Headache: 7%
- Dizziness: 4%
- Insomnia: 3%
- Somnolence: 2%
Psychiatric:
- Nervousness: 4%
- Anxiety: 2%
- Fatigue: 4%
Critical Safety Concerns
Hepatotoxicity: At doses 5-fold higher than standard (up to 300 mg/day), naltrexone causes hepatocellular injury in a substantial proportion of patients, with 19% developing transaminase elevations 3-19 times baseline 1. While this occurs at supratherapeutic doses, liver function monitoring remains important.
Precipitated Withdrawal: The most serious risk is precipitating severe opioid withdrawal in patients not completely free of exogenous opioids. This can cause severe agitation (96.2% of cases), altered consciousness (38.6%), and requires emergency management 2. Patients must be opioid-free for 7-10 days before initiation 1.
Psychiatric Effects: Depression and suicidal ideation occur at similar rates to placebo (0-15% vs 0-17% for depression; 0-1% vs 0-3% for suicide attempts), though naltrexone does not reduce suicide risk in these populations 1.
Predictors of Nausea Risk
Younger age, female gender, shorter abstinence duration, and lighter drinking patterns predict higher nausea risk, suggesting opioid system alterations from alcohol use 3. Starting with 25 mg before advancing to 50 mg daily can mitigate this.
Gabapentin Side Effects
Most Common Adverse Effects
Per FDA labeling and clinical guidelines 4, 5:
Neurological (dose-dependent):
- Dizziness and sedation (most prominent)
- Lack of coordination
- Drowsiness/somnolence
- Ataxia
- Tremor
- Difficulty with speaking
Other Common Effects:
- Viral infection
- Nausea and vomiting
- Fever
- Unusual eye movements/double vision
- Peripheral edema (swelling of legs and feet)
Serious Safety Concerns
Respiratory Depression: Emerging data implicate gabapentin in respiratory depression and overdose deaths, particularly when combined with opioids or other CNS depressants 6. This has led some states to reclassify it as Schedule V.
Psychiatric Effects:
- Severe vivid nightmares can occur and significantly impair quality of life 7
- Suicidal thoughts and behavior risk (FDA black box warning) 4
- Depression and mood changes
Accidental Injury: Sedation and dizziness increase fall risk and impair driving ability 4. Patients should avoid operating heavy machinery until effects are known.
Dosing Considerations to Minimize Side Effects
Gabapentin requires careful titration starting at 100-300 mg at bedtime or three times daily, with gradual increases over 1-7 days as tolerated 5. The nonlinear pharmacokinetics (saturable absorption) necessitate slow dose escalation to reduce dizziness and sedation. Dose reduction is mandatory in renal insufficiency.
Key Clinical Pitfalls
For Naltrexone:
- Never initiate without confirming complete opioid abstinence (7-10 days minimum)
- Discontinue before procedures requiring opioid analgesia
- Avoid in uncontrolled hypertension (can increase blood pressure) 8
- Monitor for early nausea (first week) and consider 25 mg starting dose in high-risk patients
For Gabapentin:
- Start low and titrate slowly to minimize dizziness/sedation
- Adjust dose for renal function (creatinine clearance-based) 5
- Warn patients about fall risk and driving impairment
- Monitor for psychiatric symptoms, especially in patients under 24 years
- Avoid abrupt discontinuation
- Exercise extreme caution when combining with opioids or other CNS depressants
Drug Interactions:
- Naltrexone: Avoid with MAO inhibitors (within 14 days) and all opioid medications 8
- Gabapentin: Space antacids containing aluminum/magnesium by at least 2 hours 4
Both medications are generally well-tolerated when appropriately prescribed, but their distinct side effect profiles require individualized risk assessment and patient counseling to optimize safety and adherence.